Kisunla for Alzheimer’s Now 40% Safer
July 10, 2025
Why Did Europe Finally Choose Lecanemab for Alzheimer’s?
Europe originally said Lecanemab (Brand-name Leqembi) was too risky to approve. Now they are recommending marketing it. Why the change of heart? (Video)
Source:
Related:
Ensuring Lecanemab Reaches Those Who Need It
June 5, 2025
Best Time to Stop Medicine for Dementia
May 29, 2025
Lecanemab’s Rare and Manageable Side Effects
May 23, 2025
How Many People Take Leqembi?
May 5, 2025
Email me when people comment
Login
0 Comments
Edited by:
Peter Berger
With experience in dementia caregiving, public education, and Alzheimer’s-focused writing—and a professional research background shaped in what many consider one of the world’s top laboratories—I work to make complex findings clear, practical, and genuinely helpful for families and professionals providing care.
Welcome. About this Site.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Share this page To
Dementia Books & Videos on Amazon:
More From Alzheimer's Weekly
Drugs
Massive Investment in Alzheimer’s Drug Kisunla
Ely Lilly unveils new $1,000,000,000 facility for drugs including Kisunla for Alzheimer’s. New investment will enhance global medicine production, benefiting millions of patients worldwide
No Comments
Diagnosis
Men Treat Stroke Faster than Women
Women with strokes caused by blood clots arrive at the hospital an average 27 minutes later than men, a delay that can damage brain cells and lead to vascular dementia. Read the startling statistics, and learn what to do about it.
No Comments
Prevention
Medicine & Myth: What Causes Alzheimer’s and What Doesn’t
PREVENTION: Which of these cause Alzheimer’s: 1) Flu shots? 2) Aluminum? 3) Statin drugs? See the latest research.
3 Comments
Books
The Easiest Way to Sell More Alzheimer’s Books—Week by Week
Selling Alzheimer’s books takes time – buyers rarely commit right away. Smart authors plan for the long game, offering gentle, repeated reminders to buy. No tool does this more effectively or simply than the Alzheimer’s & Dementia Weekly Newsletter service. Keep your book—and its message—at the center of your readers’ attention.
No Comments
Share to Facebook
Twitter
LinkedIn
Welcome. About this Site.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Visit Alzheimer's Weekly On